Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 336 Patent - How do you spell relief?

Please explain how issuing a PR that states that the '336 has withstood yet ANOTHER attack would "impede, impair, frustrate or otherwise interfere with the activities of TPL in the execution of the commercialization program contemplated by the Commercialization Agreement".

PTSC's ability to inform its investors and the marketplace of positive developments that are ALREADY public information regarding it's material and critical assets does not conflict with the clause you cite. Only a very narrow and intentionally-harmful-towards-PTSC TPL perspective could justify keeping PTSC from issuing a PR on this issue based on that clause.

This is not secret, non-public proprietary information.

Share
New Message
Please login to post a reply